| Working Groups |  Lingor |
| Subproject | None |
| Open Access |  Yes |
| Publication Type | Journal Article |
| Peer Reviewed | Yes |
| PMID |  38419648 |
| DOI |  10.3389/fnagi.2024.1308577 |
| Publication Year | 2024 |
| Title | Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD). |
| Journal | Frontiers in aging neuroscience |
| ISSN | 1663-4365 |
| ESSN | 1663-4365 |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/?term=38419648%5Buid%5D |
| Pages | 1308577 |
| Volume | 16 |
| Journal Abbreviation | Front Aging Neurosci |
| Authors | Wolff AW, Bidner H, Remane Y, Zimmer J, Aarsland D, Rascol O, Wyse RK, Hapfelmeier A, Lingor P |
| First Author | Wolff AW |
| Last Author | Lingor P |
